QUIZLET Unit 2 - Drug Receptors and Pharmacodynamics (1) Flashcards

(90 cards)

1
Q

Actions/effects of the drug on the body

A

Pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Specific molecules in a biologic system with which drugs interact to produce changes in the function of the system.

A

Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It is the fundamental event that initiates the action of the drug

A

Interaction between the drug and the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

It mediates the actions of both pharmacologic agonists and antagonists

A

Receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Specific binding region of the macromolecule.

A

Receptor site or Recognition site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Best characterized drug receptors

A

Regulatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Receptor that Mediates the action of endogenous chemical signals like neurotransmitters, autacoids, and hormones.

A

Regulatory proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Receptor thatInhibited (or less commonly, activated) by binding a drug

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dihydrofolate reductase, the receptor for methotrexate are examples of this receptor

A

Enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Na+ /K+ ATPase, the membrane receptor for digitalis are examples of this receptor

A

Transport Proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

tubulin, the receptor for colchicine, an anti-inflammatory drug are the examples of this receptor

A

Structural Proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Molecules that translate the drug-receptor interaction into a change in cellular activity

A

Effectors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

TRUE or FALSE: Some receptors are also effectors.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Transmembrane signaling mechanism in which the drug crosses the plasma membrane and acts on intracellular receptor

A

Lipid-soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Transmembrane signaling mechanism in which it regulates the opening of the ion channel (e.g. GABA, excitatory acetylcholine

A

Ligand-gated transmembrane ion channel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Transmembrane signaling mechanism in which it modulates production of an intracellular second messenger [e.g., catecholamine (epinephrine)].

A

Transmembrane receptor is coupled with an effector enzyme by G protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

G protein Receptor for β-Adrenergic amines, histamine, serotonin, glucagon, and many other hormones

A

Gs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

G protein receptor for α2-Adrenergic amines, acetylcholine (muscarinic), opioids, serotonin, and many others

A

Gi1, Gi2, Gi3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

G protein receptor for Odorants (olfactory epithelium)

A

Golf

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

G protein receptor for Neurotransmitters in brain (not yet specifically identified)

A

Go

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

G protein receptor for Acetylcholine (muscarinic), bombesin, serotonin (5-HT2), and many others

A

Gq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

G protein receptor for Photons (rhodopsin and color opsins in retinal rod and cone cells)

A

Gt1, Gt2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Conservation of water by the kidneys mediated by

A

vasopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mobilization of stored energy (breakdown of carbohydrates in the liver stimulated by

A

Catecholamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Mediates hormonal responses
Cyclic Adenosine Monophosphate (cAMP)
21
Calcium homeostasis by
parathyroid hormone
21
Measure of drug efficacy
Emax
21
Few signaling roles in a few cell types like the intestinal mucosa and vascular smooth muscle cells
Cyclic Guanosine Monophosphate (cGMP)
21
Heart rate and contraction by
beta-adrenomimetic catecholamine
21
Bind to receptors linked to G proteins while others bind to receptor tyrosine kinases.
Calcium and Phosphoinositides
21
Causes relaxation of vascular smooth muscles by a kinase-mediated mechanism
cGMP
21
Maximal response that can be produced by a drug
Emax
22
Response of a particular receptor-effector system is measured against increasing concentration of a drug.
Graded Dose-Response Curve
22
TRUE or FALSE: The smaller the EC50, the greater the potency of the drug
True
22
Measure of drug potency
EC50
22
Half-maximal effective concentration
EC50
23
Concentration of drug that produces 50% of maximal effect
EC50
24
TRUE or FALSE: Smaller concentration at EC50 = more potent
True
25
total density or concentration of receptors
Bmax
26
refers to the Total number of receptor sites.
Bmax
27
Equilibrium dissociation constant
KD
28
Concentration of drug required to bind 50% of the receptors
KD
29
Measure of the affinity of a drug for its binding site on the receptor
KD
30
TRUE or FALSE: Smaller KD means greater affinity of drug to receptor
True
31
what happens to the graph as more antagonist are added to the body?
It shifts to the right
32
Transduction process between the occupancy of receptors and production of specific effect. Highly efficient coupling can be elicited by a full agonist and spare receptors
Coupling
33
Maximal drug response is obtained at less than maximal occupation of the receptors.
Spare receptors
34
EC50=KD50
no spare receptors
35
EC50
there are still more spare receptors
36
EC50>KD50
All receptors are occupied before the EC50 is reached
37
Non-regulatory molecules of the body
Inert Binding Sites
38
It buffers the concentration of the drug
Inert Binding sites
39
Binding with these molecules will result to no detectable change in the function of the biologic system.
Inert Binding sites
40
Binds to the receptor and directly or indirectly bring about an effect.
Agonist
41
Agonists that Produces less than the full effect, even when it has saturated the receptors
Partial agonist
42
Acts as an inhibitor in the presence of a full agonist.
Partial agonist
43
a drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist.
Inverse agonist
44
Binds but do not activate the receptors.
Antagonist
45
Competes with agonist receptor.
Competitive Antagonist
46
Binds to the receptor reversibly without activating the effector system.
Competitive antagonist
47
Therapeutic implications produced by the competitive antagonist depends on the concentration of antagonist (e.g., propranolol)
Degree of inhibition
48
Therapeutic implications where a competitive antagonist depends on the concentration of agonist that is competing for binding to the receptor.
Clinical Response
49
Binds with the receptor via covalent bonds.
Irreversible Antagonist
50
More dependent on the rate of turnover of receptors.
Irreversible antagonist
51
Receptor is not available to bind the agonist.
Irreversible antagonist
52
What happens to the concentration effect curve in an irreversible antagonist
moves downward
53
Antagonist that Does not depend on interaction with the agonist's receptor
Chemical Antagonist
54
Drug that interacts directly with the drug being antagonized to remove it or to prevent it from reaching its target.
Chemical Antagonist
55
Antagonist that Makes use of the regulatory pathway
Physiologic antagonist
56
Antagonist where Effects that are less specific and less easy to control.
Physiologic Antagonist
57
Response gradually diminishes even if the drug is still there (after reaching an initial high level of response).
Receptor desensitazation
58
Graph of the fraction of a population that shows a specified response to increasing doses of a drug.
Quantal Dose-Response Curve
59
ED50
Median effective dose
60
TD50
Median toxic dose
61
LD50
Median Lethal dose
62
Ratio of the TD50 (or LD50) to the ED50 determined from the quantal dose-response curves
Therapeutic Index
63
TRUE or FALSE: A therapeutic margin of 2-100 is preferrable than an index of 2-10
True
64
Dosage range between the minimum effective therapeutic concentration or dose (MEC) and the minimum toxic concentration or dose (MTC).
Therapeutic Window
65
Maximal effect an agonist can produce if the dose is taken to very high levels.
Maximal efficacy
66
Amount of drug needed to produce a given effect
potency
67
Caused by differences in metabolism (genetic) or immunologic mechanisms
Idiosyncratic response
68
Intensity of the drug is decreased; Large dose of the drug is needed to have an effect.
Hyporeactive Response
69
Decreased sensitivity acquired as a result of exposure to the drug
Tolerance
70
Intensity of the drug is increased or exaggerated
Hyperreactive response
71
Tolerance develops after a few doses.
Tachyphylaxis
72
decrease in number of receptors.
down-regulation
73
increase in number of receptors.
up-regulation
74
Drug has been taken for a long time, then abruptly discontinued.
Overshoot Phenomenon/Rebound Hypertension
75
What to do to avoid/circumvent toxic effects?
o Give low doses o Carefully monitor the patient o Employ ancillary procedures o Use a safer drug
76